Search

Your search keyword '"C. Marquer"' showing total 59 results

Search Constraints

Start Over You searched for: Author "C. Marquer" Remove constraint Author: "C. Marquer"
59 results on '"C. Marquer"'

Search Results

1. Traumatismes et résiliences chez les enfants de 3 à 6ans dans trois quartiers de Port-au-Prince après le séisme de 2010 en Haïti

2. Mutating the cholesterol binding site on amyloid precursor protein alters the processing and production of Aβ-amyloid peptides (Oral)

3. [Trauma and resilience among children 3 to 6 years old in three neighborhoods of Port-au-Prince after the 2010 earthquake in Haiti]

4. Moxisylyte: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence

5. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study

6. High-performance liquid chromatographic determination of the conjugate metabolites of moxisylyte in human plasma and urine

7. Pharmacokinetics of Moxisylyte in Healthy Volunteers After Intravenous Infusion and Intracavernous Administration With and Without a Penile Tourniquet

8. Pharmacokinetics of a prodrug thymoxamine: Dose-dependence of the metabolite ratio in healthy subjects

9. Pharmacokinetics of moxisylyte in healthy volunteers after intracavernous injection of increasing doses

12. Libya, children in the war, which place for care?

14. [Effects of an extract of the bark of Pygeum africanum (V.1326) on prostatic secretions in the rat and in man]

15. Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda.

16. Practices and challenges related to antibiotic use in paediatric treatment in hospitals and health centres in Niger and Uganda: a mixed methods study.

17. Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease.

18. Lysosomal phospholipase A2 contributes to the biosynthesis of the atypical late endosome lipid bis(monoacylglycero)phosphate.

19. Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ Peptides.

20. Triplication of Synaptojanin 1 in Alzheimer's Disease Pathology in Down Syndrome.

21. An exploratory qualitative study of caregivers' knowledge, perceptions and practices related to hospital hygiene in rural Niger.

22. Development of a patient rated scale for mental health global state for use during humanitarian interventions.

23. Intrahousehold management and use of nutritional supplements during the hunger gap in Maradi region, Niger: a qualitative study.

24. Hand hygiene compliance and environmental contamination with gram-negative bacilli in a rural hospital in Madarounfa, Niger.

25. A screening tool for psychological difficulties in children aged 6 to 36 months: cross-cultural validation in Kenya, Cambodia and Uganda.

26. Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer's Disease.

27. Cell Size and Growth Rate Are Modulated by TORC2-Dependent Signals.

28. The gender, social and cultural influences on the management and use of unconditional cash transfers in Niger: a qualitative study.

29. Arf6 controls retromer traffic and intracellular cholesterol distribution via a phosphoinositide-based mechanism.

30. Maternal perception of emotional difficulties of preschool children in rural Niger.

31. Screening for psychological difficulties in young children in crisis: complementary cross-cultural validation.

32. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.

33. Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus.

34. Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes.

35. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study.

36. Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients.

37. Intra-household use and acceptability of Ready-to-Use-Supplementary-Foods distributed in Niger between July and December 2010.

38. A rapid screening tool for psychological distress in children 3-6years old: results of a validation study.

39. Determination of lipid raft partitioning of fluorescently-tagged probes in living cells by Fluorescence Correlation Spectroscopy (FCS).

40. Homodimerization of amyloid precursor protein at the plasma membrane: a homoFRET study by time-resolved fluorescence anisotropy imaging.

41. Muscarinic toxins.

42. Structural model of ligand-G protein-coupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor.

43. Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis.

44. Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes.

45. Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol.

46. Influence of MT7 toxin on the oligomerization state of the M1 muscarinic receptor.

47. Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor.

48. Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states.

49. Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7.

50. How three-finger-fold toxins interact with various cholinergic receptors.

Catalog

Books, media, physical & digital resources